Long noncoding RNA GAS5 inhibits malignant proliferation and chemotherapy resistance to doxorubicin in bladder transitional cell carcinoma
暂无分享,去创建一个
[1] Yixue Xue,et al. Long Non-coding RNA TUSC7, a Target of miR-23b, Plays Tumor-Suppressing Roles in Human Gliomas , 2016, Front. Cell. Neurosci..
[2] B. Dai,et al. Long non-coding RNA LOC572558 inhibits bladder cancer cell proliferation and tumor growth by regulating the AKT-MDM2-p53 signaling axis. , 2016, Cancer letters.
[3] Yan Guo,et al. Silence of long noncoding RNA UCA1 inhibits malignant proliferation and chemotherapy resistance to adriamycin in gastric cancer , 2016, Cancer Chemotherapy and Pharmacology.
[4] Hui Wang,et al. Downregulation of LncRNA GAS5 causes trastuzumab resistance in breast cancer , 2016, Oncotarget.
[5] Hua Ye,et al. Long noncoding RNA GAS5 suppresses the migration and invasion of hepatocellular carcinoma cells via miR-21 , 2016, Tumor Biology.
[6] Yuchen Liu,et al. Increased expression of SUMO1P3 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer , 2016, Oncotarget.
[7] Jun Zhang,et al. Long noncoding RNA MEG3 is downregulated in cervical cancer and affects cell proliferation and apoptosis by regulating miR-21 , 2016, Cancer biology & therapy.
[8] Tao Chen,et al. Expression of long noncoding RNA lncRNA-n336928 is correlated with tumor stage and grade and overall survival in bladder cancer. , 2015, Biochemical and biophysical research communications.
[9] Daling Zhu,et al. Long non-coding RNA growth arrest-specific transcript 5 is involved in ovarian cancer cell apoptosis through the mitochondria-mediated apoptosis pathway. , 2015, Oncology reports.
[10] Zhengqin Gu,et al. Long non-coding RNA-GAS5 acts as a tumor suppressor in bladder transitional cell carcinoma via regulation of chemokine (C-C motif) ligand 1 expression , 2015, Molecular medicine reports.
[11] Zheng Li,et al. Long non-coding RNA growth arrest-specific transcript 5 in tumor biology. , 2015, Oncology letters.
[12] Xiaoqiang Guo,et al. GAS5 Inhibits Gastric Cancer Cell Proliferation Partly by Modulating CDK6 , 2015, Oncology Research and Treatment.
[13] Tang Yiwei,et al. HOTAIR Interacting with MAPK1 Regulates Ovarian Cancer skov3 Cell Proliferation, Migration, and Invasion , 2015, Medical science monitor : international medical journal of experimental and clinical research.
[14] Juhyun Song,et al. ASK1 modulates the expression of microRNA Let7A in microglia under high glucose in vitro condition , 2015, Front. Cell. Neurosci..
[15] Piero Carninci,et al. Expression analysis of the long non-coding RNA antisense to Uchl1 (AS Uchl1) during dopaminergic cells' differentiation in vitro and in neurochemical models of Parkinson's disease , 2015, Front. Cell. Neurosci..
[16] J. Hou,et al. Increased expression of SPRY4-IT1 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer. , 2015, International journal of clinical and experimental pathology.
[17] E. Kebebew,et al. Epigenetic regulation of the lncRNA MEG3 and its target c-MET in pancreatic neuroendocrine tumors. , 2015, Molecular endocrinology.
[18] Meng Li,et al. Silencing of Long Noncoding RNA MALAT1 by miR-101 and miR-217 Inhibits Proliferation, Migration, and Invasion of Esophageal Squamous Cell Carcinoma Cells* , 2014, The Journal of Biological Chemistry.
[19] H. Weng,et al. MALAT1 promotes the proliferation and metastasis of gallbladder cancer cells by activating the ERK/MAPK pathway , 2014, Cancer biology & therapy.
[20] P. Gontero*,et al. Intravesical thermo-chemotherapy based on conductive heat: a first pharmacokinetic study with Mitomycin C in superficial transitional cell carcinoma patients , 2014, Cancer Chemotherapy and Pharmacology.
[21] Jun-Tao Jiang,et al. Downregulation of GAS5 Promotes Bladder Cancer Cell Proliferation, Partly by Regulating CDK6 , 2013, PloS one.
[22] N. Malats,et al. Epidemiology of urinary bladder cancer: from tumor development to patient’s death , 2007, World Journal of Urology.
[23] M. Droller,et al. Current concepts in assessment and treatment of bladder cancer , 2000, Current opinion in urology.